本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

216.95
-3.6500-1.65%
盘后216.950.00000.00%19:04 EDT
成交量:58.08万
成交额:1.28亿
市值:135.19亿
市盈率:-49.11
高:223.91
开:220.68
低:216.03
收:220.60
52周最高:248.60
52周最低:124.06
股本:6,231.61万
流通股本:6,008.34万
量比:1.65
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
净资产收益率:-818.43%
总资产收益率:-6.86%
市净率:-71.92
市盈率(LYR):-49.11

数据加载中...

2021/05/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/10

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/10

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]